UK regulator chief says AstraZeneca vaccine benefits firmly outweigh risks
LONDON, March 18 (Reuters) - The benefits of the Oxford/AstraZeneca COVID-19 vaccine firmly outweigh the risks, the head of Britain's medicines regulator on Thursday said after five reports of rare blood clots in the brain after receiving the sho...
Read more